MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5402/2012/512732

Медицинская библиотека · ISRN obstetrics and gynecology · 2012

A high dose intravenous immunoglobulin therapy for women with four or more recurrent spontaneous abortions.

Yamada Hideto, Takeda Masamitsu, Maezawa Yoko, Ebina Yasuhiko, Hazama Ryoichi, Tanimura Kenji, Wakui Yukio, Shimada Shigeki

СтатьяПеревод в очереди

Аннотация

Recurrent spontaneous abortion (RSA) may have immunological etiology. The aim of this study was to assess the efficacy of a high dose intravenous immunoglobulin (HIVIg) therapy, in which 20 g of intact type immunoglobulin was infused daily for 5 days during early gestation, for women who had a history of four or more consecutive spontaneous abortions of unexplained etiology. A total of 60 pregnant RSA women underwent HIVIg therapy, and the pregnancy outcome was assessed. The live birth rate was 73.3% (44/60). Fifteen pregnancies ended in spontaneous abortion, and one ended in intrauterine fetal death. In 11 of the 15 spontaneous abortions, fetuses had abnormal chromosome karyotype. When the 11 pregnancies with abnormal chromosome karyotype were excluded, the live birth rate was as high as 89.8% (44/49). The HIVIg therapy may be effective for severe cases of unexplained RSA.

Для цитирования: Yamada Hideto, Takeda Masamitsu, Maezawa Yoko, Ebina Yasuhiko, Hazama Ryoichi, Tanimura Kenji, Wakui Yukio, Shimada Shigeki. A high dose intravenous immunoglobulin therapy for women with four or more recurrent spontaneous abortions.. ISRN obstetrics and gynecology. 2012. DOI: 10.5402/2012/512732.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.